Stockreport

Merck Weighs New HIV Approval Against Mixed Oncology Trial Results [Yahoo! Finance]

Merck & Company, Inc. (new)  (MRK) 
Last merck & company, inc. (new) earnings: 4/28 06:45 am Check Earnings Report
US:NYSE Investor Relations: investors.merck.com/home/default.aspx
PDF Merck (NYSE:MRK) received FDA approval for IDVYNSO, a once daily, two drug HIV 1 regimen that is non INSTI and tenofovir free. The new regimen showed non inferior eff [Read more]